BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2002
View Archived Issues
New licensing agreement signed by JT for JTE-522
Read More
Systemic antitumor response follows s.c. or intrahepatic suicide cell-based vaccination
Read More
New antedrugs with therapeutic potential in psoriasis
Read More
Potential therapeutic agent for Chagas' disease enters development
Read More
Natural plant pigment exerts chemopreventive effects in mouse colon cancer model
Read More
Wyeth-Ayerst engineers new transgenic rat model for ALS research
Read More
Vernalis and Roche collaborate on diabetes drug development
Read More
Morphine-sparing analgesic effects demonstrated for valdecoxib in knee replacement surgery trial
Read More
Shareholder approval for Millennium and Cor Therapeutics merger
Read More
aaiPharma licenses rights to Tanatril in U.S.
Read More
FDA approves BioStratum's IND for antiangiogenesis agent
Read More
CCL's Aspirair technology incorporated into Vectura business
Read More
AVI BioPharma licenses calicivirus patent
Read More
Patient enrollment begins for ALVAC-CEA/B7.1 study in colorectal cancer
Read More
Discovery Therapeutics changes name to Aderis
Read More
TAK-457 may be more effective than amphotericin B as Rx for invasive pulmonary aspergillosis
Read More
Preparation and use of new glucagon receptor antagonists/inverse agonists patented by Novo Nordisk
Read More
Pfizer synthesizes JAK3 inhibitors potentially useful as immunosuppressants
Read More
Recent patent discloses NMDA NR2B antagonists designed at Merck
Read More
Novel factor Xa inhibitors for treatment of thromboembolic disorders
Read More
Eisai seeks FDA clearance for new indication of Aciphex/Pariet
Read More
Tripeptide prodrugs of therapeutic agents with improved toxicity profile prepared at Corixa
Read More